Synovial sarcoma a DNA flow cytometric study

The relationship between DNA content, clinicopathologic findings, and patient survival in synovial sarcoma was investigated. Patient age at diagnosis (P < 0.001), tumor size (P < 0.001), and ploidy status (P < 0.003) correlated significantly with patient survival. A marginally significant correlation between mitotic count and patient survival was also observed (P = 0.04). Histologic subtypes (monophasic versus biphasic), mitotic count, and S‐phase by flow cytometry had no significant influence on the clinical outcome of patients with synovial sarcoma in this study. The authors conclude that DNA ploidy analysis is a significant objective probe in the prognostication of patients with synovial sarcoma.

[1]  A. Rydholm,et al.  Prognostic factors in synovial sarcoma , 1989, Cancer.

[2]  C. Cornelisse,et al.  DNA-aneuploidy in rhabdomyosarcomas as compared with other sarcomas of childhood and adolescence. , 1988, Human pathology.

[3]  W. McGuire,et al.  Flow cytometry, cellular DNA content, and prognosis in human malignancy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Braylan,et al.  Flow cytometric analysis of DNA in bone and soft‐tissue tumors using nuclear suspensions , 1987, Cancer.

[5]  J. Mirra,et al.  Synovial sarcoma with squamous differentiation of its mesenchymal glandular elements. A case report with light-microscopic, ultramicroscopic, and immunologic correlation. , 1984, The American journal of surgical pathology.

[6]  I W Taylor,et al.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. , 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[7]  B. Barlogie,et al.  Characterization of hematologic malignancies by flow cytometry. , 1980, Analytical and quantitative cytology and histology.

[8]  J Schumann,et al.  Cellular DNA content as a marker of neoplasia in man. , 1980, The American journal of medicine.

[9]  P. McCormack,et al.  Surgical treatment of tendosynovial sarcoma , 1979, Cancer.

[10]  J. Fortner,et al.  Tendosynovial sarcoma. A clinicopathological study of 136 Cases , 1977, Cancer.

[11]  D. H. Mackenzie.  Monophasic synovial sarcoma–a histological entity? , 1977, Histopathology.

[12]  W. Göhde,et al.  Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle , 1975, Radiation and environmental biophysics.

[13]  D. H. Mackenzie.  Synovial sarcoma. A review of 58 cases , 1966, Cancer.

[14]  P. Kelly,et al.  Synovial sarcoma. An Analysis of 134 Tumors , 1965, Cancer.

[15]  D. Crocker,et al.  Synovial sarcoma in children , 1959, Cancer.

[16]  E. S. King,et al.  Tissue differentiation in malignant synovial tumours. , 1952, The Journal of bone and joint surgery. British volume.

[17]  S. Radio,et al.  Flow cytometric DNA analysis of malignant fibrous histiocytoma and related fibrohistiocytic tumors. , 1988, Human pathology.

[18]  B. Tribukait,et al.  DNA flow analysis of soft tissue tumors , 1987, Cancer.

[19]  W. Hiddemann,et al.  Differential pattern of DNA-aneuploidy in human malignancies. , 1985, Pathology, research and practice.

[20]  R. Zito.  SYNOVIAL SARCOMA: AN AUSTRALIAN SERIES OF 48 CASES , 1984, Pathology.

[21]  H. Evans.  Synovial sarcoma. A study of 23 biphasic and 17 probable monophasic examples. , 1980, Pathology annual.